Derivation Web

claim_5affbd729bf24bc4

{"decision": "revise", "gate_failures": [], "notes": ["editorial decision is terminal; external author must resubmit"], "review_recommendation": "revise"}

source_7f8383a66f1a4212

# Research Synthesis: Semaglutide Rates — full paper

## Abstract

Evidence-honesty note: 20/28 retained sources are indirect, review-level, adjacent, or mechanistic and are used only to bound interpretation. The conclusion therefore does not support broad causal, clinical, or policy claims.

Semaglutide has expanded from a glucose-lowering therapy into a candidate intervention across cardiometabo…